Synthesis and investigation of the conversion reactions of pyrimidine-thiones with nucleophilic reagent and evaluation of their acetylcholinesterase, carbonic anhydrase inhibition, and antioxidant activities

J Biochem Mol Toxicol. 2018 Feb;32(2). doi: 10.1002/jbt.22019. Epub 2017 Dec 28.

Abstract

The conversion reactions of pyrimidine-thiones with nucleophilic reagent were studied during this scientific research. For this purpose, new compounds were synthesized by the interaction between 1,2-epoxy propane, 1,2-epoxy butane, and 4-chlor-1-butanol and pyrimidine-thiones. These pyrimidine-thiones derivatives (A-K) showed good inhibitory action against acetylcholinesterase (AChE), and human carbonic anhydrase (hCA) isoforms I and II. AChE inhibition was in the range of 93.1 ± 33.7-467.5 ± 126.9 nM. The hCA I and II were effectively inhibited by these compounds, with Ki values in the range of 4.3 ± 1.1-9.1 ± 2.7 nM for hCA I and 4.2 ± 1.1-14.1 ± 4.4 nM for hCA II. On the other hand, acetazolamide clinically used as CA inhibitor showed Ki value of 13.9 ± 5.1 nM against hCA I and 18.1 ± 8.5 nM against hCA II. The antioxidant activity of the pyrimidine-thiones derivatives (A-K) was investigated by using different in vitro antioxidant assays, including Cu2+ and Fe3+ reducing, 1,1-diphenyl-2-picrylhydrazyl (DPPH ) radical scavenging, and Fe2+ chelating activities.

Keywords: acetylcholinesterase; antioxidant activity; carbonic anhydrase; enzyme inhibition; pyrimidine-thiones.

Publication types

  • Comparative Study

MeSH terms

  • Acetazolamide / chemistry
  • Acetazolamide / pharmacology
  • Acetylcholinesterase / chemistry
  • Acetylcholinesterase / metabolism
  • Antioxidants / chemical synthesis
  • Antioxidants / chemistry
  • Antioxidants / pharmacology*
  • Carbonic Anhydrase Inhibitors / chemical synthesis
  • Carbonic Anhydrase Inhibitors / chemistry
  • Carbonic Anhydrase Inhibitors / pharmacology*
  • Carbonic Anhydrases / chemistry
  • Carbonic Anhydrases / isolation & purification
  • Carbonic Anhydrases / metabolism
  • Cholinesterase Inhibitors / chemical synthesis
  • Cholinesterase Inhibitors / chemistry
  • Cholinesterase Inhibitors / pharmacology*
  • Drug Design*
  • Humans
  • Iron Chelating Agents / chemical synthesis
  • Iron Chelating Agents / chemistry
  • Iron Chelating Agents / pharmacology
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / isolation & purification
  • Isoenzymes / metabolism
  • Kinetics
  • Molecular Structure
  • Nootropic Agents / chemical synthesis
  • Nootropic Agents / chemistry
  • Nootropic Agents / pharmacology
  • Pyrimidines / chemical synthesis
  • Pyrimidines / chemistry
  • Pyrimidines / pharmacology*
  • Thiones / chemical synthesis
  • Thiones / chemistry
  • Thiones / pharmacology*
  • Transition Temperature

Substances

  • Antioxidants
  • Carbonic Anhydrase Inhibitors
  • Cholinesterase Inhibitors
  • Iron Chelating Agents
  • Isoenzymes
  • Nootropic Agents
  • Pyrimidines
  • Thiones
  • Acetylcholinesterase
  • Carbonic Anhydrases
  • Acetazolamide